Prescription drug abuse has become the fastest growing drug problem in the nation. In far too many instances the problem is caused by health care workers who divert patient medication for their own use or use by others.
Like other issues of patient safety, and public safety, the most effective approach is prevention. A report recently released by the Controlled Substance Diversion Coalition provides health care organizations with important information and “best practices” to prevent drug thefts in health care facilities.
In May, 2011, the Minnesota Department of Health and the Minnesota Hospital Association convened the Controlled Substances Diversion Coalition to address the serious issue of medication diversion in health care facilities. The Coalition is made up of representatives from health care providers, licensing boards and other regulatory agencies, public health officials and law enforcement authorities. Because hospital and other health care facilities are required to file a report with the U.S. Drug Enforcement Administration within 24 hours after a controlled substance is lost or stolen, the D.E.A.’s records provide insight into the prevalence of the problem in Minnesota.
From 2005 to 2011, there were 250 reports of theft or loss of controlled substances associated with health care workers. Within that time frame, reported incidents increased 325%. It is harder to quantify the resulting impact on patient safety when health care workers are impaired by chemical use, or sometimes feed their addiction by depriving patients of needed medications.
Importantly, the Coalition went beyond identifying the problem. In a groundbreaking collaboration that included providers and law enforcement, the Coalition produced best practices related to controlled substance management on issues such as storage and security, procurement, prescribing, preparation and dispensing, and handling waste. A Controlled Substance Diversion Prevention Roadmap and a Controlled Substance Diversion Prevention Tool Kit were prepared, the latter containing one hundred best practices for preventing and responding to controlled substances diversions.
The Coalition’s work will be invaluable to the health care industry, and to the health care lawyers who have been called upon to advise clients on how to follow-up when diversion is suspected. The Coalition’s report provides analysis of a number of important issues that frequently arise in drug diversion matters. For example, the report addresses the following key questions:
If you have questions about the Coalition’s report or issues related to prescription drug diversion, please contact Susan Gaertner at 612.632.3355 or email@example.com.
Check List: Responding to Suspected Drug Theft
Controlled Substances and Enforcement: Drug Diversion Reporting Requirements
Maintaining Control of Controlled Substances Presentation
This article is provided for general informational purposes only and should not be construed as legal advice or legal opinion on any specific facts or circumstances. You are urged to consult a lawyer concerning any specific legal questions you may have.
Gray Plant Mooty is recognized as one of the leading corporate law firms in Minnesota and one of the top franchise firms in the world. Our roots go back to 1866. Today, we are a 180-plus attorney, full-service firm with offices in Minneapolis and St. Cloud, Minnesota; Washington, D.C.; and Fargo, North Dakota.